Oral magnesium ion shortens prolonged QTc interval [3]

Journal of Clinical Psychiatry

Volumn 64, Issue 6, 2003, Pages 733-734

  Bachman, Daniel M ^a  

^a Eastern Oregon Psychiatric Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; NEUROLEPTIC AGENT;

ADULT; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; ELECTROCARDIOGRAM; FEMALE; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LETTER; LONG QT SYNDROME; MALE; PATIENT CARE; PRIORITY JOURNAL; QT INTERVAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TORSADE DES POINTES;

EID: 0038548589     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0618d     Document Type: Letter

References (6)

1. Warner JP, Henry JA. Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr Scand 1996;93: 311-313
2. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993;72 (suppl 8):23B-25B
3. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: International Consensus on Science [letter]. Circulation 2000;102(8, suppl):I123-I124
4. Reilly JG, Ayis SA, Ferrier IN, et al. QTc interval abnormalities and psychotropic drug therapy in psychiatric patients. The Lancet 2000;355:1044-1052
5. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and pro-arrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Euro Heart J 2000;21:1216-1231
6. Brentano CF, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol 1993;72(suppl 8):17B-22B